Organization Profile

You just read:

Independent Study Finds Intravenous Vernakalant Facilitates Electrical Cardioversion in Patients with Cardioversion Resistant Atrial Fibrillation

News provided by

Cardiome Pharma Corp.

Jun 12, 2015, 08:30 ET